FREE Case Review (866) 588-0600

Canadian Zofran Labels Warn of Birth Defects, Plaintiffs Find

Plaintiffs who are involved in the Zofran multidistrict litigation in Boston have made the discovery that drug labels in Canada make a warning against using the drug during pregnancy, unlike its U.S. label.

Plaintiffs involved in the Zofran multidistrict litigation (MDL 2657) in Boston have discovered that labels of the drug in Canada warn against use during pregnancy, unlike the U.S. label.

Free Confidential Lawsuit Evaluation: If your child was born with heart defects, a cleft palate, kidney defects or other problems after the mother took Zofran during pregnancy, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?

February 10, 2016 – The Canadian Zofran label reads that “the safety of ondansetron for use in human pregnancy has not been established,” and “use in pregnancy is not recommended.”

Plaintiffs in the MDL who allege birth defects from Zofran are wondering why the same warnings were not provided to American patients.

MDL 2657 Status Update

More than 200 lawsuits have been consolidated against GlaxoSmithKline (GSK) in MDL 2657. The complaints allege that Zofran caused plaintiffs’ children to be born with a wide variety of severe birth defects including atrial septal defect, ventricular septal defect, transposition of the great vessels, respiratory distress syndrome, clubfoot, kidney defects and cleft palate.

Questions of Fact

The U.S. Judicial Panel on Multidistrict Litigation (JPML) determined that consolidation of Zofran lawsuits was appropriate because each complaint contains similar ‘questions of fact,’ including:

  • Was a birth defect the result of Zofran use during pregnancy?
  • Did GSK illegally market the drug for the treatment of morning sickness?
  • Did the company fail to disclose evidence linking Zofran to birth defects?

When Will the Trials Begin?

Before any trials can begin, the discovery phase must take place. Discovery is a procedure in which each party can obtain evidence from the other party or parties by means of discovery devices such as a request for answers to interrogatories, request for production of documents, request for admissions and/or depositions. The discovery phase of the MDL has not yet begun, although it is expected soon. Judge F. Dennis Saylor has appointed co-lead counsel and will soon appoint the Plaintiff’s Steering Committee. After that, it is likely the litigation process will proceed quickly.

Do I Have a Zofran Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.

Free Case Evaluation: Again, if your child or other loved one was inured by Zofran side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a class action suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition